Your browser doesn't support javascript.
loading
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI.
Ducrocq, Gregory; Bhatt, Deepak L; Lee, Jane J; Kui, Naishu; Fox, Kim M; Harrington, Robert A; Leiter, Lawrence A; Mehta, Shamir R; Kiss, Róbert Gábor; James, Stefan; Vinereanu, Dragos; Huber, Kurt; Andersson, Marielle; Himmelmann, Anders; Simon, Tabassome; Steg, Ph Gabriel.
Affiliation
  • Ducrocq G; Université de Paris, AP-HP, French Alliance for Cardiovascular Trials (FACT), INSERM U1148, Paris, France.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA.
  • Lee JJ; Baim Institute for Clinical Research, Boston, MA.
  • Kui N; Baim Institute for Clinical Research, Boston, MA.
  • Fox KM; Imperial College, Royal Brompton Hospital, London, UK.
  • Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA.
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada.
  • Mehta SR; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada.
  • Kiss RG; Magyar Honvédség Egészségügyi Központ, Budapest, Hungary.
  • James S; Uppsala University, Uppsala, Sweden.
  • Vinereanu D; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania.
  • Huber K; 3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital and Sigmund Freud University, Medical Faculty, Vienna, Austria.
  • Andersson M; AstraZeneca BioPharmaceuticals Research and Development, Gothenburg, Sweden.
  • Himmelmann A; AstraZeneca BioPharmaceuticals Research and Development, Gothenburg, Sweden.
  • Simon T; Sorbonne Université, APHP.SU, Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris (URC-CRC-CRB), Hôpital St Antoine, FACT, Paris, France.
  • Steg PG; Université de Paris, AP-HP, French Alliance for Cardiovascular Trials (FACT), INSERM U1148, Paris, France; Imperial College, Royal Brompton Hospital, London, UK. Electronic address: gabriel.steg@aphp.fr.
Am Heart J ; 249: 23-33, 2022 07.
Article in En | MEDLINE | ID: mdl-35321823
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Stroke / Diabetes Mellitus / Percutaneous Coronary Intervention / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am Heart J Year: 2022 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Stroke / Diabetes Mellitus / Percutaneous Coronary Intervention / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am Heart J Year: 2022 Type: Article Affiliation country: France